Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Dose-Ranging Study of Quadrivalent VLP Influenza Vaccine in Healthy Adults
NCT02307851Phase 2Completed
- Sponsor
- Novavax
- Start
- Nov 2014
- Primary completion
- Jun 2015
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Quadrivalent VLP Vaccine in influenza, sponsored by Novavax. Started Nov 2014; status: completed.
02
Drugs
Quadrivalent VLP Vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02307851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02307851.